NATROX® Wound Care, an Inotec AMD brand, is a specialist wound care company based in Cambridge, England formed specifically to introduce innovative technologies to healthcare professionals around the world. The company’s mission is to promote faster and better healing to patients suffering with chronic wounds. Their flagship product, NATROX® Oxygen Wound Therapy, is positioned to be an integral part of global wound care treatment regimes in the coming years. With its foundation in 2003, the company operates within the Health Care and Medical Devices industries.
The most recent milestone for NATROX® Wound Care was the Series C investment on 02 December 2024. This significant investment underscores the confidence and support the company has garnered, reflecting the industry's recognition of their potential to transform the quality of life for patients with chronic wounds.
For more information, visit: natroxwoundcare.com.